Ignite Creation Date:
2024-07-17 @ 12:02 PM
Last Modification Date:
2025-12-16 @ 9:27 PM
Study NCT ID:
NCT06498518
Status:
None
Last Update Posted:
2025-07-11 00:00:00
First Post:
2024-07-02 00:00:00
Brief Title:
A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor:
Karen Carty
Organization:
University of Glasgow
Organization Data
Organization:
University of Glasgow
Class:
OTHER
Study ID:
PRIMUS006-2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Karen Carty
Lead Sponsor Class:
OTHER
Responsible Party:
Karen Carty
Responsible Party Title:
Mrs
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Glasgow
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NHS Greater Glasgow and Clyde | OTHER |
| University of Glasgow | OTHER |